ARTV

Artiva Biotherapeutics
ARTV

Overview Fund Trends Analyst Outlook Journalist POV

48 hedge funds and large institutions have $319M invested in Artiva Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$152M
2
+$36.4M
3
+$24.9M
4
VP
venBio Partners
California
+$23.5M
5
Capital World Investors
Capital World Investors
California
+$14.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$304K
27
$288K
28
$275K
29
$229K
30
$166K
31
$157K
32
$135K
33
$118K
34
$116K
35
$102K
36
$81.2K
37
$45.4K
38
$42.1K
39
$40.2K
40
$32K
41
$22K
42
$21.5K
43
$20.1K
44
$16.1K
45
$11.1K
46
$7K
47
$2.47K
48
$479
1
2